Skip to main content

NCBiotech News

  • BioFluidica, a Chapel Hill company developing a product using liquid biopsies for cancer detection. has completed a $2 million Series A funding round.
  • CivaTech Oncology, a Research Triangle Park company developing cancer therapy devices with funding help from the North Carolina Biotechnology Center, is featured in an abstract that will get a “Best in Show” award at an upcoming scientific meeting.
  • North Carolina’s life science jobs continue to grow at more than triple the national average, pushing the total num
  • Seventy-one companies headquartered in 20 countries now have a presence in North Carolina, employing more than 17,000 people in the state, where they have made capital investments totaling well over $2.5 billion in the past five years alone.
  • Carver Nichols, a senior honor student at Brevard High School, was a finalist in the BioGENEius Challenge, an international science fair in which North Carolina's lone 2016 finalist competed against 14 others from the United States, Canada and Germany.
  • Wilmington physician Alan Brown, an impassioned inventor in his off hours, has transformed two of his ideas into award-winning product innovations – a self-illuminating speculum and a corneal marking system – designed to make eye surgeries more efficient and accurate, improving patient outcomes.
  • A group headlined by blazingly successful life science rainmaker Steve Butts, MBA, is hanging out a shingle in Morrisville, this time with $49 million in early funding support. They’re calling it Arrivo BioVentures.
  • The uniquely futuristic billion-dollar cell culture Seqirus vaccine factory in Holly Springs has hit another milestone, with U.S. Food and Drug Administration marketing approval for the FLUCELVAX QUADRIVALENT flu vaccine made there.
  • Panacea BioMatx, a personalized nutrition startup company in Morrisville, has signed a license agreement with an Australian health food provider that will also invest up to $1 million in Panacea, while existing North Carolina investors in Panacea have also agreed to match the investment on similar terms.
  • Two North Carolina agricultural biotechnology leaders share their thoughts on the continuing need for innovation in agriculture, and North Carolina's growing power in driving the sector.
  • Custom development and manufacturing organization Alcami Corporation is hosting a public open house at its Durham facility on Thursday, May 19, from 11:30 a.m. to 3:30 p.m.
  • A Morehead City company using innovative materials to help restore North Carolina oyster habitats is among 11 finalists vying for $50,000 funding packages in the spring 2016 round of NC IDEA grants.
  • A dozen agricultural biotechnology companies from North Carolina, seven other states and even a European startup from Portugal will share their breakthrough technologies for crop and animal health advancements at the day-long Ag Biotech Entrepreneurial Showcase 2016 May 18 at the North Carolina Biotechnology Center.
  • FUJIFILM Diosynth Biotechnologies held a ribbon-cutting ceremony today to celebrate the opening of a 62,000-square-foot facility in Morrisville to house its bioprocess R&D groups.
  • Research Triangle Park-based medical diagnostics company BioMedomics has received approval from the Kenya Ministry of Health to sell Sickle SCAN, the company’s portable and quick-reporting test system for sickle cell disease (SCD) and sickle cell trait (SCT).
  • Plans for a new kind of agricultural technology startup company started to take shape today with the announcement of an $11.5 million AgTech Accelerator corporation in Research Triangle Park.
  • Bioscience briefs with names making news
  • One of the most significant incubators of small businesses in North Carolina is celebrating National Small Business Week with a visit from its district’s Congressman. And all four First Flight Venture Center (FFVC) startup companies making “Shark Tank”-type pitches to the audience are being bootstrapped with loans from the North Carolina Biotechnology Center.
  • Global generic drug maker Aurobindo Pharma said today it will invest over $31.7 million to establish a new national headquarters in Durham that will  bring 275 new R&D and pharmaceutical manufacturing jobs to the Triangle.
  • The North Carolina Biotechnology Center awarded 21 grants and loans totaling $2.5 million to companies, universities and nonprofit organizations across the state during the third quarter of its 2015-2016 fiscal year ending March 31.


Subscribe to News & Events